Objectives Ireland currently administers a universal BCG vaccination programme to infants.
In order to assess the cost effectiveness of this programme, it is vital to have accurate cost …

Background The burden of childhood tuberculosis remains high globally, largely due to
under-diagnosis. Decentralising childhood tuberculosis diagnosis services to lower health …

Background The aim of this study was to compare the cost effectiveness of the current Irish
programme of universal BCG vaccination of infants versus a programme which considered …

Tuberculosis (TB) remains a disease of high morbidity in Australia, with implications for both
public health and the individual. Cost analyses is relevant for programmatic evaluation of …

OBJECTIVE: To estimate the cost of treating a tuberculosis (TB) case and to analyse TB-
related medical service utilisation, a cost-of-illness study was conducted for all patients with …

Background. Little up-to-date information is available about the costs of providing drug-
susceptible tuberculosis (DS-TB) treatment to paediatric patients in South Africa (SA), nor …

BACKGROUND: There is a dearth of economic analysis required to support increased
investment in TB in India. This study estimates the costs of TB services from a health …

Background Over 1 million children aged 0 to 14 years were estimated to develop
tuberculosis in 2021, resulting in over 200,000 deaths. Practical interventions are urgently …

Introduction Tuberculosis (TB) incidence in England and Wales has fallen by 44% since
2011 with England now classed as a low incidence area. This means that individual …

Background Tuberculosis remains the leading cause of death in South Africa. A number of
potential new TB vaccine candidates have been identified and are currently in clinical trials …